Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 4:47 pm Purchase | 2021-12-31 | 13G | GEMINI THERAPEUTICS INC GMTX | SUVRETTA CAPITAL MANAGEMENT LLC | 237,227 5.500% | 13,943 (+6.24%) | Filing History |
| 2022-02-11 4:45 pm Purchase | 2021-12-31 | 13G | SIO GENE THERAPIES INC SIOX | SUVRETTA CAPITAL MANAGEMENT LLC | 5,914,000 8.100% | 425,000 (+7.74%) | Filing History |
| 2022-02-11 4:38 pm Purchase | 2021-12-31 | 13G | CANO HEALTH INC CANO | SUVRETTA CAPITAL MANAGEMENT LLC | 105,476 5.800% | 18,387 (+21.11%) | Filing History |
| 2022-02-11 4:37 pm Purchase | 2021-12-31 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | SUVRETTA CAPITAL MANAGEMENT LLC | 45,710,335 8.400% | 13,882,835 (+43.62%) | Filing History |
| 2022-02-11 4:24 pm Purchase | 2021-12-31 | 13G | EYEPOINT INC EYPT | SUVRETTA CAPITAL MANAGEMENT LLC | 3,482,109 9.990% | 1,886,945 (+118.29%) | Filing History |
| 2022-02-11 4:19 pm Purchase | 2021-12-31 | 13G | FULCRUM THERAPEUTICS INC FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 2,375,571 5.900% | 578,653 (+32.20%) | Filing History |
| 2021-12-16 4:32 pm Purchase | 2021-12-06 | 13G | AEGLEA BIOTHERAPEUTICS, INC. C AGLE | SUVRETTA CAPITAL MANAGEMENT LLC | 102,840 5.200% | 102,840 (New Position) | Filing History |
| 2021-12-10 4:31 pm Purchase | 2021-11-30 | 13G | SUTRO BIOPHARMA INC STRO | SUVRETTA CAPITAL MANAGEMENT LLC | 240,840 5.200% | 240,840 (New Position) | Filing History |
| 2021-12-09 4:31 pm Purchase | 2021-11-29 | 13G | KURA ONCOLOGY INC KURA | SUVRETTA CAPITAL MANAGEMENT LLC | 3,503,419 5.300% | 3,503,419 (New Position) | Filing History |
| 2021-11-29 4:39 pm Purchase | 2021-11-18 | 13G | BOLT BIOTHERAPEUTICS, INC BOLT | SUVRETTA CAPITAL MANAGEMENT LLC | 111,513 6.000% | 111,513 (New Position) | Filing History |
| 2021-10-15 4:49 pm Purchase | 2021-10-05 | 13G | GEMINI THERAPEUTICS INC GMTX | SUVRETTA CAPITAL MANAGEMENT LLC | 223,284 5.200% | 133,338 (+148.24%) | Filing History |
| 2021-09-17 4:54 pm Purchase | 2021-09-07 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,296,452 5.300% | 1,296,452 (New Position) | Filing History |
| 2021-08-20 4:36 pm Purchase | 2021-08-10 | 13G | MARINUS PHARMACEUTICALS INC MRNS | SUVRETTA CAPITAL MANAGEMENT LLC | 2,052,358 5.600% | 2,052,358 (New Position) | Filing History |
| 2021-08-10 5:05 pm Purchase | 2021-08-04 | 13G | FULCRUM THERAPEUTICS INC FULC | SUVRETTA CAPITAL MANAGEMENT LLC | 1,796,918 5.500% | 1,796,918 (New Position) | Filing History |
| 2021-07-30 4:42 pm Purchase | 2021-07-20 | 13G | CANO HEALTH INC CANO | SUVRETTA CAPITAL MANAGEMENT LLC | 87,089 5.100% | 47,089 (+117.72%) | Filing History |
| 2021-07-26 5:21 pm Purchase | 2021-07-14 | 13G | EYEPOINT INC EYPT | SUVRETTA CAPITAL MANAGEMENT LLC | 1,595,164 5.600% | 1,595,164 (New Position) | Filing History |
| 2021-05-07 4:46 pm Purchase | 2021-04-28 | 13G | BENITEC BIOPHARMA INC BNTC | SUVRETTA CAPITAL MANAGEMENT LLC | 45,235 9.800% | 45,235 (New Position) | Filing History |
| 2021-04-23 4:30 pm Purchase | 2021-04-14 | 13G | FINTECH ACQUISITION CORP V CL FTCV | SUVRETTA CAPITAL MANAGEMENT LLC | 1,901,890 7.400% | 1,901,890 (New Position) | Filing History |
| 2021-04-22 4:02 pm Purchase | 2021-04-12 | 13G | OTONOMY INC OTIC | SUVRETTA CAPITAL MANAGEMENT LLC | 6,018,878 9.990% | 6,018,878 (New Position) | Filing History |